​The GI-MAP test is a comprehensive stool analysis available on the market. It provides insights into the condition of the gastrointestinal tract.

The test focuses on specific microbes that may disrupt the normal balance of the microbiome, potentially causing digestive issues and other chronic health conditions. It is suitable for individuals’ experiencing constipation, diarrhea, bloating, reflux, stomach pain, irritable bowel syndrome, inflammatory bowel diseases; inflammatory skin conditions such as acne, psoriasis, eczema; mood disorders including depression and anxiety.

Additionally, this test can be helpful for those with hormonal imbalances, as it measures Beta glucuronidase levels which can impact estrogen detoxification, potentially leading to estrogen dominant conditions. Anxiety and depression may also be influenced by gut bacteria, with research suggesting the gut plays a significant role in brain health.

The GI-MAP screens the body for commensal and pathogenic bacteria, parasites, fungi, opportunistic pathogens, and viruses, all of which can impact health if imbalanced. It also assesses leaky gut, pancreatic function, gut immune response, and gut-mediated inflammation, providing a detailed overview of the gastrointestinal tract's condition, allowing for the formulation of effective treatments tailored to individual needs.